Risk-Benefit Framing for GLP-1 Therapies

You can have a completely normal BMI and be on your way to cardiovascular disease, type 2 diabetes, and metabolic syndrome without triggering a single alert on a standard health screening. The fat that predicts metabolic risk most accurately isn't the fat your scale or your doctor is tracking. Dr. Jordan Feigenbaum breaks down the science of visceral fat — what it is, how it causes disease, how to measure it correctly at home for free, and what the evidence actually shows about exercise, GLP-1 medications, and testosterone.

Timestamps:

• 00:00:00 Cold Open: The Visceral Fat Finding
• 00:00:49 The Scale Problem — What Body Weight Actually Measures
• 00:03:50 What Is Visceral Fat — and Why It's Not Just "Belly Fat"
• 00:05:04 Three Competing Theories: How Visceral Fat Actually Causes Disease
• 00:08:35 Adipokines: PAI-1, Angiotensinogen, and What Happens When Adiponectin Drops
• 00:09:52 How to Measure: Three Sites That Don't Give the Same Number
• 00:14:30 Clinical Thresholds, Ethnic Adjustments, and the Waist-to-Height Ratio
• 00:15:45 The Weight-to-Waist Ratio: Tracking the Quality of Your Fat Loss
• 00:19:20 Sleep, Cortisol, and Why the Hormonal Environment Has to Support the Work
• 00:21:24 Why Exercise Reduces Visceral Fat 6× More Than Diet Alone
• 00:22:02 Mechanism 1 — Beta-3 Adrenergic Receptors and Preferential Visceral Fat Mobilization
• 00:24:10 Mechanism 2 — Myokines: The Fat-Burning Signal Only Contracting Muscle Can Send
• 00:26:21 GLP-1 Agonists and Body Composition: What the Clinical Trials Actually Show
• 00:28:05 DXA's Blind Spot: Myosteatosis, Glycogen, and Why Lean Mass Numbers Are Inflated
• 00:30:10 SEMALEAN, the BELIEVE Trial, and the 1-in-10 Reality of Long-Term Lifestyle Programs
• 00:33:15 Testosterone, Visceral Fat, and the Aromatase Feed-Forward Loop
• 00:36:05 Three Testosterone Ranges: Deficient, Eugonadal, and Supraphysiological
• 00:38:05 The Bhasin 4-Group Study — and Why AAS Are a Class, Not a Synonym for TRT
• 00:39:33 Tesamorelin: The GHRH Analogue That Selectively Targets Visceral Fat
• 00:40:53 Practical Framework: What to Measure, When, and What to Do
• 00:43:20 Key Takeaways

Next Steps

• For evidence-based resistance training programs: barbellmedicine.com/training-programs
• For individualized training consultation: barbellmedicine.com/coaching
• Explore our full library of articles on health and performance: barbellmedicine.com/resources
• To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/
• To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com
• Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/

Resources:

• https://pubmed.ncbi.nlm.nih.gov/11502820/
• https://pubmed.ncbi.nlm.nih.gov/33567185/
• https://pubmed.ncbi.nlm.nih.gov/35658024/
• https://pubmed.ncbi.nlm.nih.gov/40318682/
• https://pubmed.ncbi.nlm.nih.gov/41068996/
• https://pubmed.ncbi.nlm.nih.gov/41772149/
• https://pubmed.ncbi.nlm.nih.gov/23944298/
• https://pubmed.ncbi.nlm.nih.gov/20948519/
• https://pubmed.ncbi.nlm.nih.gov/27213481/
• https://pubmed.ncbi.nlm.nih.gov/23303913/